Position in VTGN
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$8,662
-$148 QoQ
Shares Held
15,198
+13.9% QoQ
Ownership
0.037%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VTGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026StoneX Group Inc. holds $1,825,991 across 16 Biotechnology names. VTGN ranks #10 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,482 | $661,772 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
1,469 | $473,297 | |
| 3 | HRMY |
Harmony Biosciences Holdings, Inc.
|
12,631 | $353,794 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
3,650 | $235,899 | |
| 5 | CDXS |
Codexis, Inc.
|
14,096 | $22,976 | |
| 6 | RNXT |
RenovoRx, Inc.
|
12,728 | $12,855 | |
| 7 | MREO |
Mereo BioPharma Group plc
|
36,873 | $12,168 | |
| 8 | HUMA |
Humacyte, Inc.
|
16,205 | $9,836 |
All Filings in VTGN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,662 | 15,198 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $8,810 | 13,349 | Shares | Defined | 2026-02-12 | |
| No filing history on record for this holder in this stock. | ||||||